Distribution of prognostically unfavourable product of c-erbB-2 oncogene and EGF-R in carcinomas of the breast and uterine cervix.
Indian J Physiol Pharmacol
;
2002 Oct; 46(4): 423-33
Artículo
en Inglés
| IMSEAR
| ID: sea-108582
ABSTRACT
A comparative study was undertaken between cancer of the uterine cervix (n = 50) and female breast cancer (n = 50) with reference to the expression of c-erbB-2 oncoprotein (HER-2/neu) and that of epidermal growth factor receptor (EGF-R), both being highly homologous structurally. Expressions of EGF-R and c-erbB-2 oncoprotein were viewed in breast and cervical cancer tissues by immunochemical staining. Cervical cancer cases showed much higher expression of EGF-R which also revealed significant association with the expression of c-erbB-2 oncoprotein and tumour grading. Among breast cancer cases, over-expression of EGF-R correlated significantly with metastasis of lymph node; and expression of c-erbB-2 oncoprotein showed a significant relationship with histological grading of the tumour. Moreover, an association was noticed between the tumour grade and the concomitant immuno positive expression of EGF-R and c-erbB-2. Our study revealed an existence of a conflicting pattern in the expression of EGF-R and c-erbB-2 oncoprotein between carcinomas of the breast and uterine cervix.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Neoplasias Uterinas
/
Neoplasias de la Mama
/
Femenino
/
Humanos
/
Carcinoma de Células Escamosas
/
Regulación Neoplásica de la Expresión Génica
/
Carcinoma Ductal de Mama
/
Receptor ErbB-2
/
Adulto
/
Receptores ErbB
Tipo de estudio:
Estudio pronóstico
Idioma:
Inglés
Revista:
Indian J Physiol Pharmacol
Año:
2002
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS